BMS-986288
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986288, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers [Phase 1, Phase 2]